← FDA Drug Approvals (Drugs@FDA)

VALSARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RENATA · Approved 2024-08-05

Drug application

FDA Application #

ANDA218169

Application type

Abbreviated New Drug Application (Generic)

Brand name

VALSARTAN

Generic name

Valsartan

Active ingredients

VALSARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

RENATA

First approval

2024-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown